- 期刊
Dual versus Single Antiplatelet Therapy in Medically Treated Acute Myocardial Infarction Patients with Baseline Thrombocytopenia - Insights from a Multi-Institute Cohort Study
摘要
Background: The safety and efficacy of dual antiplatelet therapy (DAPT) in medically treated acute myocardial infarction (AMI) patients with baseline thrombocytopenia (platelet count ＜ 150 × 10^3/uL) are unclear. Methods: In this multi-institute retrospective cohort study, we included 468 patients with medically treated AMI with baseline thrombocytopenia and separated them into single antiplatelet therapy (SAPT) and DAPT groups according to the discharge anti-thrombotic strategy. The primary outcome was net clinical adverse events (NACEs), defined as a composite of death, ischemic events (myocardial infarction, ischemic stroke, and transient ischemic attack), and major bleeding within 30 days. Results: There were 168 patients in the SAPT group (100 taking aspirin and 68 taking clopidogrel) and 300 in the DAPT group. A primary outcome occurred in 35 (24.11 per 100 patient-months) patients in the SAPT group and 39 (14.26 per 100 patient-months) patients in the DAPT group [adjusted hazard ratio (HR): 0.67; 95% confidence interval (CI): 0.40-1.10; p = 0.1145]. Kaplan-Meier curves showed favorable results in the DAPT group (log-rank p = 0.0243). Bleeding events occurred in 18 (10.71 per 100 patient-months) patients in the SAPT group and 18 (6.40 per 100 patient-months) patients in the DAPT group (adjusted HR: 0.66; 95% CI: 0.32-1.36; p = 0.2573). Conclusions: DAPT versus SAPT as discharge anti-thrombotic strategy in thrombocytopenic patients with medically treated AMI did not significantly improve NACEs at 30 days. However, there was a trend towards favorable outcomes in the DAPT group. These results should be interpreted carefully with respect to the relatively limited trial population and study design.
延伸閱讀
- Wang, Y. H. (2017). Treatment Patterns and Outcomes Study of Antithrombotic Use in Atrial Fibrillation Patients Presenting with Acute Coronary Syndrome or Percutaneous Coronary Intervention [master's thesis, National Taiwan University]. Airiti Library. https://doi.org/10.6342/NTU201703850
- Wang, Y. H., Kao, H. L., Wang, C. C., Lin, S. Y., & Lin, F. J. (2019). Comparative Effectiveness and Safety of Antithrombotic Therapy in Atrial Fibrillation Patients Presenting with Acute Coronary Syndrome or Percutaneous Coronary Intervention. Acta Cardiologica Sinica, 35(5), 508-521. https://doi.org/10.6515/ACS.201909_35(5).20190311A
- 張永明（2012）。Analysis of AngioJet Thrombectomy on Myocardial Perfusion and Six-month Survival for Patients with Acute ST-elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention〔碩士論文，中山醫學大學〕。華藝線上圖書館。https://doi.org/10.6834/CSMU.2012.00047
- Lin, C. C., Lee, P. Y., Chen, K. C., Liao, P. C., Hsu, J. C., & Li, A. H. (2020). Clinical, Demographic, and Biochemical Characteristics of Patients with Acute ST-Segment Elevation Myocardial Infarction: An Analysis of Acute Coronary Syndrome Registry Data of a Single Medical Center from 2005 to 2016. Acta Cardiologica Sinica, 36(1), 1-7. https://doi.org/10.6515/ACS.202001_36(1).20190704D
- Mischke, K., Knackstedt, C., & Marx, N. (2012). Anticoagulant and Antiplatelet Therapy in Patients with Atrial Fibrillation and Coronary Artery Disease. Thrombosis, 2012(), 64-71. https://doi.org/10.1155/2012/184573